Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Moderna Inc (NQ: MRNA )

125.00 -0.59 (-0.47%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 3, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,512,927
Open 125.00
Bid (Size) 125.35 (2)
Ask (Size) 125.48 (9)
Prev. Close 125.59
Today's Range 122.01 - 126.40
52wk Range 62.55 - 142.79
Shares Outstanding 383,000,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Navigating 6 Analyst Ratings For Moderna
Via Benzinga
3 Growth Stocks You’ll Kick Yourself for Not Buying Today
Netflix, Intuit, and Vertex Pharmaceuticals are three growth stocks to buy, each positioned for significant market share and returns. 
Via InvestorPlace

Performance

YTD
+11.11%
+11.11%
1 Month
+20.64%
+20.64%
3 Month
+26.24%
+26.24%
6 Month
+75.49%
+75.49%
1 Year
-3.95%
-3.95%

More News

Read More
Shhh! 3 Secret Pharma Stocks Flying Below Wall Street’s Radar
Via InvestorPlace
Why Moderna Stock Blasted 13% Higher Today
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Moderna Reports First Quarter 2024 Financial Results and Provides Business Updates
Via ACCESSWIRE
$1000 Invested In This Stock 5 Years Ago Would Be Worth $4,100 Today
Via Benzinga
Smart Money Is Betting Big In MRNA Options
Via Benzinga
Wall Street Inches Up After Powell's Inflation Remarks; Chipmakers Rebound; Gold, Crude Falter: What's Driving Markets Thursday?
Via Benzinga
Topics Economy
Exposures Interest Rates
Moderna Reports Smaller Than Expected Q1 Loss, Prepares For RSV Vaccine And Spikevax 2024-2025 Formula, Stock Soars
Via Benzinga
Exposures COVID-19
Merck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week
Via Benzinga
Topics Stocks
Exposures US Equities
Should You Buy Moderna Before May 12?
Via The Motley Fool
Moderna (MRNA) Q1 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
MRNA Stock Earnings: Moderna Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
C.H. Robinson Worldwide Posts Upbeat Results, Joins Avis Budget Group, Qualcomm, BorgWarner, Moderna And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Moderna Puts Up Big Quarterly Beat; Could Shares Notch A Breakout?
Via Investor's Business Daily
Nasdaq, S&P 500 Futures Rise Ahead Of Apple Earnings: Why This Analyst Thinks 'No Cut' Scenario May Not Be Negative For Market
Via Benzinga
Topics Stocks
Exposures US Equities
Stock Market Crash Warning: Don’t Get Caught Holding These 3 Cathie Wood Stocks
Via InvestorPlace
Shhh! 3 Secret Biotech Stocks Flying Below Wall Street’s Radar
Via InvestorPlace
3 Biotech Stocks with Blockbuster Drug Pipelines: April Edition
Via InvestorPlace
mRNA Is Promising A Breakthrough In Fighting Cancer
Via Benzinga
Exposures COVID-19
3 Beaten-Down Stocks I Wouldn't Touch With a 10-Foot Pole
Via The Motley Fool
Nasdaq Bull Market: Here's the Best Investing Move You Can Make Right Now
Via The Motley Fool
All In on Microsoft Stock: How AI Turned MSFT Into the Hottest Tech Play of 2024
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.